| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Cryocor Raises $5.45 Million In Private Placement
Posted on 04/26/2007 10:26:56 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
San Diego-basedCryoCor (CRYO) has raised $5.45 million in a private placement with a group of accredited investors. The company sold 1,052,423 shares of common stock priced at a closing bid price of $5.14 per share.
CryoCor’s signature product, the Cryoablation System, treats cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The product has been on the market in Europe since 2002 for the treatment of atrial fibrillation and atrial flutter, the two most common and difficult-to-treat arrhythmias. The company is pursuing similar availability in the U.S. Earlier this month, CryoCor got word that FDA’s advisory panel will meet in June or July to review a pre-market application for using the Cryoablation System to treat atrial flutter; a trial is underway for the atrial fibrillation indication.
Source: OneMedPlace.com
RELATED READING:
- Inovio Biomedical: Tumor Ablation Technology Tempting to Big Pharmas
____________________
Med Tech Sentinel
San Diego-basedCryoCor (CRYO) has raised $5.45 million in a private placement with a group of accredited investors. The company sold 1,052,423 shares of common stock priced at a closing bid price of $5.14 per share.
CryoCor’s signature product, the Cryoablation System, treats cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The product has been on the market in Europe since 2002 for the treatment of atrial fibrillation and atrial flutter, the two most common and difficult-to-treat arrhythmias. The company is pursuing similar availability in the U.S. Earlier this month, CryoCor got word that FDA’s advisory panel will meet in June or July to review a pre-market application for using the Cryoablation System to treat atrial flutter; a trial is underway for the atrial fibrillation indication.
Source: OneMedPlace.com
RELATED READING:
- Inovio Biomedical: Tumor Ablation Technology Tempting to Big Pharmas
____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- The Average Joe Investor
- Wishing Wealth
- Financial Skeptic
- Edmonton Real Estate
- Don't Mess With Taxes
- Poor and Stupid
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Tue Jul 22, 2008 09:23AM
Hedge funds have made billions this year shorting the banks, [read more]
Hedge funds have made billions this year shorting the banks, [read more]
<< My Home | TheMoneyBlogs Home